Abstract
BackgroundCheckpoint inhibitors revolutionized the treatment of metastatic melanoma patients. Although tumor burden and lactate dehydrogenase (LDH) are associated with overall survival (OS), the impact of tumor growth kinetics remains elusive...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have